Hiperos to Present at Anti-Corruption Compliance Conference for International Pharmaceutical Industry - wistv.com - Columbia, South Carolina |

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: Hiperos

Provider of 3rd Party Management Solutions to Share Insights into New Directions and Possibilities Opening up in Compliance Arena for Pharmaceutical Companies

Somerville, NJ (PRWEB) December 10, 2012

Hiperos, the leading provider of Software as a Service solutions for 3rd party management (3PM), announced today that CEO Greg Dickinson will be presenting at the Pharmaceutical Anti-Corruption Compliance Conference taking place in Philadelphia on December 10–12. Dickinson’s presentation, scheduled for 10:20 a.m. EST on December 11, will address a dynamic mix of senior compliance, legal, audit, and supply chain executives, and explore new ways for international pharmaceutical companies to think about their compliance challenges and their use of technology-based and other critical solutions. For information on this exclusive event, please visit http://compliance-pharma.com/. Interested parties can also visit http://www.hiperos.com for more information on anti-corruption strategies and solutions.

The cornerstone of federal anti-corruption regulation is the Foreign Corrupt Practices Act (FCPA), which makes it unlawful for multinational companies traded on the U.S. stock exchanges, individuals, and 3rd party intermediaries to pay foreign government officials to help retain or obtain business. In part because of widespread sales and marketing practices involving government-owned or managed hospitals abroad, pharmaceuticals is one of the industries most susceptible to FCPA regulatory action.

In light of newly-issued FCPA guidelines, Dickinson’s upcoming presentation is both timely and informative, and will provide insights into the recent changes in today’s regulatory environment and the impact on business conditions, corporate risk and governance obligations. Dickinson will also illustrate how specific pharmaceutical companies are utilizing Hiperos’ SaaS technology in innovative ways to effectively manage their 3rd parties and thereby address risk, compliance and performance.

About Hiperos
Hiperos simplifies the complexity of 3rd Party Management (3PM). Through its flagship SaaS (Software-as-a-Service) solution, Hiperos helps companies avoid a value shortfall and fully realize the benefits of using 3rd parties to maximize the value and minimize the risk around brand reputation, achieve regulatory compliance and optimize the customer experience. Hiperos’ clients include many of the world’s leading companies such as Aetna, AON, Astra Zeneca, Bank of Montreal, CA Technologies, Charles Schwab, MasterCard, Microsoft, PNC Bank, State Street, TD Bank, and United Technologies. For more information, visit http://www.hiperos.com.

# # #

Press Contacts:
Marie-Charlotte Patterson
Hiperos
W: +1.908.981.0060
mpatterson(at)hiperos(dot)com

Carmen Hughes
Ignite Public Relations
W: +1.650.227.3280 ext. 101
C: +1.650.576.6444
carmen(at)ignitepr(dot)com

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012_hiperos/pharmapresentation/prweb10215652.htm